Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
6
Frequently Asked Questions
What is Market Cap of Galmed Pharmaceuticals Ltd?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Galmed Pharmaceuticals Ltd market cap is $7.67M.
What is the 52-week high for Galmed Pharmaceuticals Ltd?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Galmed Pharmaceuticals Ltd 52 week high is $7.50 as of September 28, 2025.
What is the 52-week low for Galmed Pharmaceuticals Ltd?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Galmed Pharmaceuticals Ltd 52 week low is $1.15 as of September 28, 2025.
What is Galmed Pharmaceuticals Ltd stock price today?
Galmed Pharmaceuticals Ltd stock price today is $1.40.
What was Galmed Pharmaceuticals Ltd stock price yesterday?
Galmed Pharmaceuticals Ltd stock price yesterday was $1.38.
What is the PE ratio of Galmed Pharmaceuticals Ltd?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Galmed Pharmaceuticals Ltd’s P/E ratio is -0.26.
What is the Price-to-Book ratio of Galmed Pharmaceuticals Ltd?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Galmed Pharmaceuticals Ltd P/B ratio is 0.3618.
What is the 50-day moving average of Galmed Pharmaceuticals Ltd?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Galmed Pharmaceuticals Ltd 50-day moving average is $1.52.
How many employess does Galmed Pharmaceuticals Ltd has?
